secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001140361-25-041591
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis Q3 revenue $2.2M, down 6% YoY, up 29% sequentially; operating loss widens to $2.7M
--------------------------------------------------------------------------------

- Total revenue $2.2M, down 6% YoY but up 29% sequentially; pro-forma revenue grew ~7% YoY excluding one-time items.
- Gross margin 65.2% (down from 70% YoY); operating loss $2.7M vs $1.5M last year.
- Cash $3.1M at quarter end, debt-free; raised $1.9M via ATM facility.
- Launched new 24-hour circuit and dual-lumen catheter; first hospital-based outpatient therapies under new CMS code.
- Pediatric Vivian system accelerated with NIH funding; manufacturing transition to KDI Precision initiated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036125041591/0001140361-25-041591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036125041591/ef20058643_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-041591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer